AI and brain scans aim to predict who is at risk for suicide
NCT ID NCT07484906
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aimed to enroll 150 people at different risk levels for self-harm to understand how brain activity and blood markers relate to suicide risk. Participants would have received brain scans, blood tests, and three different treatments (neurofeedback, transcranial magnetic stimulation, and psilocybin therapy). The goal was to use artificial intelligence to find patterns that could accurately identify high-risk individuals. However, the study was withdrawn before any participants were enrolled.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SUICIDAL IDEATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can money worries trigger depression in students? a study digs deep
- Special forces veterans test Psychedelic-Device combo for PTSD and brain injury
- Self-Defense as healing: could a culturally grounded program ease trauma in native women?
- Veterans helping veterans: Peer-Led program aims to prevent suicide in those with serious mental illness
- Can a sleep app help save teens from suicide?
- Can a brief talk therapy session prevent suicide in the military?